Tyrphostin AG 1296 induces glioblastoma cell apoptosis in vitro and in vivo

Oncology Letters
Hongwei LiXianhou Yuan

Abstract

Glioblastoma is the most common type of malignant human brain tumor. Currently available chemotherapies for glioblastoma focus on targeting tyrosine kinases. However, the existing inhibitors of tyrosine kinases have not produced the therapeutic outcomes that were anticipated. In order to investigate the viability alternative chemotherapeutic agents in this disease, the present study examined the anticancer effects of tyrphostin AG 1296, focusing on its involvement in apoptosis in glioblastoma cells. The study aimed to identify whether tyrphostin AG 1296 affects glioblastoma cell growth by inducing cell apoptosis. To achieve this, cell viability, propidium iodide analysis and cell invasion assay were used to measure cell growth, cell apoptosis and cell migration of human glioblastoma cells. The results showed that tyrphostin AG 1296 treatment reduced cell viability and suppressed migration of human glioblastoma cells. It was also demonstrated that tyrphostin AG 1296 induced cell apoptosis in vitro. Finally, tyrphostin AG 1296 was also shown to significantly inhibit the growth of glioblastoma cells and to increase tumor cell apoptosis in vivo. These findings suggest that tyrphostin AG 1296 induces apoptosis, thereby reducing cell...Continue Reading

References

Jan 17, 1995·International Journal of Cancer. Journal International Du Cancer·A GuhaC D Stiles
Aug 24, 1999·Pharmacology & Therapeutics·A Levitzki
Oct 3, 1999·Physiological Reviews·C H Heldin, B Westermark
Oct 18, 2000·Advances in Cancer Research·A Ostman, C H Heldin
Jun 8, 2001·Genes & Development·E A MaherR A DePinho
Sep 11, 2001·The American Journal of Pathology·D N LouisJ G Cairncross
Jul 18, 2002·Nature Reviews. Drug Discovery·Renaud CapdevilleAlex Matter
Jul 15, 2005·The New England Journal of Medicine·Daniela S Krause, Richard A Van Etten
Aug 18, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patrick Y WenMichael D Prados
Aug 23, 2006·Laboratory Investigation; a Journal of Technical Methods and Pathology·Brian P Rubin, Anette Duensing
Apr 8, 2009·Critical Reviews in Immunology·Hideho OkadaMitsugu Fujita
Jan 25, 2012·Current Cancer Drug Targets·T E TaylorW K Cavenee
Apr 19, 2012·Upsala Journal of Medical Sciences·Inga NazarenkoMonica Nistér
Apr 19, 2012·Lancet·Damien RicardJean-Yves Delattre
Jul 17, 2012·Hematology/oncology Clinics of North America·Kevin AntonTina Mayer
Apr 9, 2014·Cells·Estefanía Carrasco-GarcíaIsabel Martínez-Lacaci

❮ Previous
Next ❯

Citations

Dec 22, 2017·Signal Transduction and Targeted Therapy·Joshua R D Pearson, Tarik Regad

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
Assay
flow cytometry

Software Mentioned

CellQuest Pro
SPSS

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis